Home » Topics » Regulatory

Regulatory
RSS

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

New use claimed by Sanofi-Synthelabo for succinic acid derivatives

Dec. 21, 2000

GABA analogues reported to modulate substance P

Dec. 21, 2000

Questcor arranges Asian marketing agreement for metoclopramide nasal spray

Dec. 21, 2000

Vivus granted third PDE inhibitor patent

Dec. 21, 2000

Improved compositions of LHRH or somatostatin analogues described in recent patent

Dec. 20, 2000

Treatment of autoimmune diseases with Rituxan

Dec. 20, 2000

CPMP recommends approval of Visudyne therapy for treatment of pathological myopia

Dec. 19, 2000

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

FDA approves pediatric indication for Tamiflu

Dec. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026